Latest Breaking News On - Vivek jayaraman - Page 1 : comparemela.com

Cerus Corporation (NASDAQ:CERS) Q1 2024 Earnings Call Transcript

Cerus Corporation misses on earnings expectations. Reported EPS is $-0.0532 EPS, expectations were $-0.04.

United arab emiratesUnited kingdomUnited statesSaudi arabiaMatt blackmanRoss osborneJacob johnsonEmily christyJessica hanoverWilliam bonelloVivek jayaramanCarol mooreJoshua jenningsFastest growing fintech companiesCraig hallum capital groupCerus corporation

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Cerus Corporation today announced that the U.S. Food and Drug Administration has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture,.

United statesVivek jayaramanCerus corporationDrug administrationExchange commissionCerus corporation nasdaqProcessing setsCeru annual report

Cerus (CERS) Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets

Cerus (CERS) Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vivek jayaramanDrug administrationCerus corporation nasdaqCerus corporationProcessing sets

Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to Cerus Corporation Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

British columbiaSouth koreaUnited statesMatt blackmanVivek jayaramanJessica hanoverJacob johnsonWelcome to cerus corporation second quarterCerus corporationStanford medical centersTrauma anesthesiology society or taskonUs department of defenseCorporate affairsCanadian blood servicesCerus corpSociety for the advancement

Cerus Corporation (NASDAQ:CERS) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. Thank you for standing by and welcome to the Cerus Corporation’s Second Quarter 2023 Earnings Conference Call.

United statesVastra gotalands lanNew yorkJacob johnsonMathew blackmanJoshua jenningsRichard benjaminJessica hanoverCarol mooreVivek jayaramanLaurence corashGraham sherMatt blackmanCerus corporation second quarterInternational society of blood transfusionCorporate affairs